It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2005.
2005 | New Delhi, Delhi, India | ActiveSynod Pharmaceuticals Private Limited, a active private limited company, was established on 08 December 2005 in New Delhi, Delhi, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24232DL2005PTC143438. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kamal Bhushan (Director), Charanpreet Singh (Director), Rajesh Sehgal (Director). It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No- Pra-2B Pratap Nagar Metro Station, New Delhi, Delhi, 110007.
U24232DL2005PTC143438
143438
08 December 2005
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Synod Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Bhushan | Director | 08 Dec 2005 | Current |
| Charanpreet Singh | Director | 08 Dec 2005 | Current |
| Rajesh Sehgal | Director | 08 Dec 2005 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synod Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Synod Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2014 | Oriental Bank Of Commerce | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Synod Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synod Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synod Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Synod Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Synod Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Progress on A charge with Oriental Bank Of Commerce amounted to Rs. 0.50 M with Charge ID 10544151 was registered on 15 Dec 2014. was documented.
Kamal Bhushan was appointed as a Director was appointed as a Director on 08 Dec 2005 & has been associated with this company since 19 years 11 months . was recorded as a recent event.
Progress on Charanpreet Singh was appointed as a Director was appointed as a Director on 08 Dec 2005 & has been associated with this company since 19 years 11 months . was documented.
Rajesh Sehgal was appointed as a Director was appointed as a Director on 08 Dec 2005 & has been associated with this company since 19 years 11 months . was recorded as a recent event.
The CIN of Synod Pharmaceuticals Private Limited is U24232DL2005PTC143438.
Synod Pharmaceuticals Private Limited is headquartered at Shop No- Pra-2B Pratap Nagar Metro Station, New Delhi, Delhi, 110007.
Synod Pharmaceuticals Private Limited was incorporated on 08 December 2005.
The current directors of Synod Pharmaceuticals Private Limited are
The primary industry of Synod Pharmaceuticals Private Limited is Manufacturing.
Synod Pharmaceuticals Private Limited is unlisted.
The authorized capital of Synod Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Synod Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX